Cargando…

Azithromycin (Zithromax(®))

Azithromycin (Zithromax(®), Pfizer, Inc., New York, NY) is a 15-membered-ring macrolide and the first azalide antibiotic. It is distinguished from other macrolides by its rapid and extensive penetration into intracellular and interstitial tissue compartments, accompanied by prolonged tissue and seru...

Descripción completa

Detalles Bibliográficos
Autor principal: McCarty, James M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364499/
https://www.ncbi.nlm.nih.gov/pubmed/18476095
http://dx.doi.org/10.1155/S1064744996000415
_version_ 1782153968862887936
author McCarty, James M.
author_facet McCarty, James M.
author_sort McCarty, James M.
collection PubMed
description Azithromycin (Zithromax(®), Pfizer, Inc., New York, NY) is a 15-membered-ring macrolide and the first azalide antibiotic. It is distinguished from other macrolides by its rapid and extensive penetration into intracellular and interstitial tissue compartments, accompanied by prolonged tissue and serum half-lives. Azithromycin shares the gram-positive activity of erythromycin but is more potent against gram-negative organisms. For urethritis and cervicitis caused by Chlamydia trachomatis, azithromycin is effective and well tolerated in a single dose of 1 g, a regimen recommended by the CDC. A 5-day dosage regimen is available for the treatment of community-acquired respiratory-tract and skin and skin-structure infections caused by susceptible organisms. Azithromycin provides short-duration, high-compliance, cost-effective regimens that should improve outcomes.
format Text
id pubmed-2364499
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23644992008-05-12 Azithromycin (Zithromax(®)) McCarty, James M. Infect Dis Obstet Gynecol Research Article Azithromycin (Zithromax(®), Pfizer, Inc., New York, NY) is a 15-membered-ring macrolide and the first azalide antibiotic. It is distinguished from other macrolides by its rapid and extensive penetration into intracellular and interstitial tissue compartments, accompanied by prolonged tissue and serum half-lives. Azithromycin shares the gram-positive activity of erythromycin but is more potent against gram-negative organisms. For urethritis and cervicitis caused by Chlamydia trachomatis, azithromycin is effective and well tolerated in a single dose of 1 g, a regimen recommended by the CDC. A 5-day dosage regimen is available for the treatment of community-acquired respiratory-tract and skin and skin-structure infections caused by susceptible organisms. Azithromycin provides short-duration, high-compliance, cost-effective regimens that should improve outcomes. Hindawi Publishing Corporation 1996 /pmc/articles/PMC2364499/ /pubmed/18476095 http://dx.doi.org/10.1155/S1064744996000415 Text en Copyright © 1996 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
McCarty, James M.
Azithromycin (Zithromax(®))
title Azithromycin (Zithromax(®))
title_full Azithromycin (Zithromax(®))
title_fullStr Azithromycin (Zithromax(®))
title_full_unstemmed Azithromycin (Zithromax(®))
title_short Azithromycin (Zithromax(®))
title_sort azithromycin (zithromax(®))
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364499/
https://www.ncbi.nlm.nih.gov/pubmed/18476095
http://dx.doi.org/10.1155/S1064744996000415
work_keys_str_mv AT mccartyjamesm azithromycinzithromax